Form 4: Avanos Medical Executive John Joseph Hurley Reports Stock Transaction
SEC Form 4
John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc., reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On March 5, 2024, John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc., disposed of 32 shares of common stock at a price of $18.76 per share to satisfy tax withholding obligations.
- This transaction occurred due to the vesting of time-based restricted share units (TRSUs) awarded on March 4, 2022, with 1/3 vesting on March 4, 2023, 1/3 vesting on March 4, 2024, and the remaining 1/3 scheduled to vest on March 4, 2025.
- Following the transaction, Hurley directly owns 4,655 shares of Avanos Medical, Inc.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations and does not indicate a significant change in the executive's sentiment towards the company.
Future Outlook
The remaining 1/3 of the TRSUs will vest on March 4, 2025.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock.
Key Dates
| Date | Description |
|---|---|
| 03/04/2022 | Date of grant for time-based restricted share units (TRSUs) |
| 03/04/2023 | 1/3 of TRSUs vested |
| 03/04/2024 | 1/3 of TRSUs vested |
| 03/05/2024 | Date of stock disposal for tax obligations |
| 03/04/2025 | Remaining 1/3 of TRSUs will vest |
| 03/06/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.